scispace - formally typeset
P

Pal Gooz

Researcher at Medical University of South Carolina

Publications -  12
Citations -  616

Pal Gooz is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Matrix metalloproteinase & Helicobacter pylori. The author has an hindex of 8, co-authored 12 publications receiving 576 citations.

Papers
More filters
Journal ArticleDOI

Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo

TL;DR: It is demonstrated that systemic administration of CSD peptide to bleomycin-treated mice blocks epithelial cell apoptosis, inflammatory cell infiltration, and changes in tissue morphology as well as signaling molecule activation and collagen, tenascin-C, and ASMA expression associated with lung fibrosis.
Journal ArticleDOI

Opposing Effects of Protein Kinase Cα and Protein Kinase Cϵ on Collagen Expression by Human Lung Fibroblasts Are Mediated via MEK/ERK and Caveolin-1 Signaling *

TL;DR: The combined results demonstrate that a branched signaling pathway involving MEK, ERK, PKCϵ,PKCα, and caveolin-1 regulates collagen expression in normal lung tissue and is perturbed during fibrosis.
Journal ArticleDOI

Curcumin-induced apoptosis in scleroderma lung fibroblasts: Role of protein kinase Cε

TL;DR: It is suggested that a signaling pathway involving PKCepsilon and phase 2 detoxification enzymes provides protection against curcumin-induced apoptosis in NLF and is defective in SLF, just as it has already been shown to protect rats from lung fibrosis induced by a variety of agents.
Journal ArticleDOI

Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.

TL;DR: The data indicate that MMP and TIMP secretion by AGS cells is modulated by H. pylori infection and that host MMP-3 and a TIMP-3 homolog expressed by the bacterium mediate at least part of the host cell response to infection.
Journal ArticleDOI

Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease

TL;DR: Caveolin-1 downregulation in leucocytes contributes to fibrotic lung disease, highlighting caveolin- 1 as a promising therapeutic target in scleroderma.